Listed by the USPTO as GUSTILO, ESTELLA M
Tech Center 1600 • Art Units: 1644 1646
This examiner grants 54% of resolved cases
Estella M Gustilo operates in Tech Center 1600 and Art Unit 1644 with 69 resolved cases. The allowance rate pct is 53.6%, and the median days to allowance is 1279. This examiner has a moderate allowance rate pct of 53.6% and a longer timeline of 1279 median days to allowance.
The interview lift pct of 34.5% is a significant factor for applicants, as it notably improves the chances of success. Janssen Pharmaceuticals Inc., Genentech Inc., and Eli Lilly and Company are the top companies. FISH & RICHARDSON P.C. (TC), Lathrop GPM LLP, and COOLEY LLP are the primary firms. The 69 resolved cases and 34.5% interview lift pct suggest that interviews are a highly effective tool in this art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18799503 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR BLADDER CANCER | Non-Final OA | Genentech, Inc. |
| 18416031 | Anti-Jagged1 Antibodies and Methods of Use | Non-Final OA | Genentech, Inc. |
| 17284284 | EXTRACELLULAR VESICLES FOR TARGETED THERAPIES AGAINST MYELOID-DERIVED SUPPRESSOR CELLS | Final Rejection | Ohio State Innovation Foundation |
| 18818268 | ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME | Final Rejection | The General Hospital Corporation |
| 18695945 | PEANUT ALLERGY EPITOPE | Non-Final OA | Vanderbilt University |
| 18453098 | FCRN BINDING POLYPEPTIDES | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 17818854 | METHODS OF INCREASING RESPONSE TO CANCER RADIATION THERAPY | Non-Final OA | The Trustees of the University of Pennsylvania |
| 16521430 | T CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND USES THEREOF | Non-Final OA | Academisch Ziekenhuis Leiden (h.o.d.n. LUMC) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy53.6% of resolved applications examined by Estella M Gustilo were allowed (69 resolved cases), compared with 35.9% across Art Unit 1644 over the last five years.
This examiner's interview lift is +34.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Estella M Gustilo took 1,279 days on average from filing to allowance.
Estella M Gustilo examines applications in Art Unit 1644 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
